EMG
CRL icon

ETF Managers Group’s Charles River Laboratories CRL Stock Holding History

ETF Managers Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,547
Closed -$1.02M – 689
2021
Q1 		$1.02M Buy
+3,547
New +$986K 0.02% 272
2016
Q4 		$20K Sell
269
-389
-59% -$29.5K 0.09% 43
2016
Q3 		$54K Buy
+658
New +$55.2K 0.11% 42

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

ETF Managers Group's CRL Position: Q2 2021 in Review

ETF Managers Group sold out of Charles River Laboratories (CRL) in Q2 2021, closing a stake of 3,547 shares — an estimated $1.02M sold.

ETF Managers Group first reported a position in CRL in Q3 2016 and held it in 3 quarters. The position peaked at $1.02M in Q1 2021. 639 funds tracked by Wall St. Rank hold CRL as of Q2 2021.

  • ETF Managers Group reported no remaining Charles River Laboratories position as of Q2 2021 after selling out during the quarter.
  • ETF Managers Group sold 3,547 Charles River Laboratories shares in Q2 2021, an estimated $1.02M.
  • ETF Managers Group first reported a position in Charles River Laboratories in Q3 2016 and held it in 3 quarters.
  • ETF Managers Group's Charles River Laboratories position peaked at $1.02M in Q1 2021.
  • 639 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2021.

Based on ETF Managers Group's 13F filing for Q2 2021, filed 16 Aug 2021.